Simon Amos J, Lev Atar, Zhang Yong, Weiss Batia, Rylova Anna, Eyal Eran, Kol Nitzan, Barel Ortal, Cesarkas Keren, Soudack Michalle, Greenberg-Kushnir Noa, Rhodes Michele, Wiest David L, Schiby Ginette, Barshack Iris, Katz Shulamit, Pras Elon, Poran Hana, Reznik-Wolf Haike, Ribakovsky Elena, Simon Carlos, Hazou Wadi, Sidi Yechezkel, Lahad Avishay, Katzir Hagar, Sagie Shira, Aqeilan Haifa A, Glousker Galina, Amariglio Ninette, Tzfati Yehuda, Selig Sara, Rechavi Gideon, Somech Raz
Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel Division of Haematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
J Exp Med. 2016 Jul 25;213(8):1429-40. doi: 10.1084/jem.20151618. Epub 2016 Jul 18.
The analysis of individuals with telomere defects may shed light on the delicate interplay of factors controlling genome stability, premature aging, and cancer. We herein describe two Coats plus patients with telomere and genomic defects; both harbor distinct, novel mutations in STN1, a member of the human CTC1-STN1-TEN1 (CST) complex, thus linking this gene for the first time to a human telomeropathy. We characterized the patients' phenotype, recapitulated it in a zebrafish model and rescued cellular and clinical aspects by the ectopic expression of wild-type STN1 or by thalidomide treatment. Interestingly, a significant lengthy control of the gastrointestinal bleeding in one of our patients was achieved by thalidomide treatment, exemplifying a successful bed-to-bench-and-back approach.
对端粒缺陷个体的分析可能有助于揭示控制基因组稳定性、早衰和癌症的因素之间微妙的相互作用。我们在此描述了两名患有科茨综合征且伴有端粒和基因组缺陷的患者;两人均在人类CTC1-STN1-TEN1(CST)复合体成员STN1中携带独特的新突变,从而首次将该基因与一种人类端粒病联系起来。我们对患者的表型进行了特征描述,在斑马鱼模型中进行了重现,并通过野生型STN1的异位表达或沙利度胺治疗挽救了细胞和临床方面的问题。有趣的是,我们的一名患者通过沙利度胺治疗实现了对胃肠道出血的显著长期控制,例证了一种成功的从病床到实验室再回到病床的方法。
Am J Med Genet A. 2020-9
Mol Genet Genomic Med. 2021-12
Ophthalmic Genet. 2021-2
Genes Dev. 2013-10-1
J Clin Invest. 2025-6-3
Front Immunol. 2025-2-14
Nat Rev Mol Cell Biol. 2025-4
J Vitreoretin Dis. 2024-9-14
Front Aging. 2024-10-9
Transfus Med Hemother. 2024-7-30
Blood. 2014-9-18
J Cell Biol. 2014-5-12
Hum Mol Genet. 2014-7-15
Proc Natl Acad Sci U S A. 2013-7-15
Nucleus. 2013-7-10
PLoS One. 2013-6-24
N Engl J Med. 2013-6-5